FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

17669411000001109: Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Sep 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
61523201000001119 Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
102549101000001113 Daxas 500microgram tablets (AstraZeneca UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Is a Roflumilast 500microgram tablets true Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Has specific active ingredient Roflumilast false Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Is a Daxas true Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Has specific active ingredient Roflumilast true Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Has active ingredient Roflumilast true Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) 30 tablet 3 x 10 tablets Has AMP True Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) 90 tablet 9 x 10 tablets Has AMP True Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start